PUBLISHER: TechNavio | PRODUCT CODE: 1975601
PUBLISHER: TechNavio | PRODUCT CODE: 1975601
Global Direct To Consumer Laboratory Testing Market 2026-2030
The global direct to consumer laboratory testing market is forecasted to grow by USD 28569 mn during 2025-2030, accelerating at a CAGR of 36.8% during the forecast period. The report on the global direct to consumer laboratory testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global aging population statistics, shift toward proactive preventive healthcare, technological advancements in sequencing tools.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 34.8% |
| CAGR | 36.8% |
| Incremental Value | $28569 mn |
Technavio's global direct to consumer laboratory testing market is segmented as below:
By Type
- Blood
- Urine
- Saliva
- Others
By Application
- Routine clinical testing
- Diabetes testing
- Genetic testing
- Thyroid stimulating hormone testing
- Others
By Distribution Channel
- Online
- Offline
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the microbiome analysis for personalized wellness as one of the prime reasons driving the global direct to consumer laboratory testing market growth during the next few years. Also, multicancer early detection liquid biopsies and integration of telehealth with testing will lead to sizable demand in the market.
The report on the global direct to consumer laboratory testing market covers the following areas:
- Global direct to consumer laboratory testing market sizing
- Global direct to consumer laboratory testing market forecast
- Global direct to consumer laboratory testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global direct to consumer laboratory testing market vendors that include 23andMe Holding Co., Ancestry, Any Lab Test Now Inc., Dante Labs Inc., Direct Laboratory Services LLC, Eurofins Scientific SE, Everlywell Inc., Function Health Inc., Gene by Gene Ltd., Laboratory Corp., LetsGetChecked, Living DNA Ltd., Mapmygenome India Ltd., Myriad Genetics Inc., Prenetics Global Ltd., Quest Diagnostics Inc., Segterra Inc., Thorne HealthTech Inc., Ulta Lab Tests LLC, Walk In Lab LLC.. Also, the global direct to consumer laboratory testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Direct To Consumer Laboratory Testing Market 2020 - 2024
- Historic Market Size - Data Table on Global Direct To Consumer Laboratory Testing Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.4 Distribution Channel segment analysis 2020 - 2024
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Direct to Consumer Laboratory Testing Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Blood - Market size and forecast 2025-2030
- 8.4 Urine - Market size and forecast 2025-2030
- 8.5 Saliva - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Routine clinical testing - Market size and forecast 2025-2030
- 9.4 Diabetes testing - Market size and forecast 2025-2030
- 9.5 Genetic testing - Market size and forecast 2025-2030
- 9.6 Thyroid stimulating hormone testing - Market size and forecast 2025-2030
- 9.7 Others - Market size and forecast 2025-2030
- 9.8 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Market Segmentation by Distribution Channel
- 10.1 Market segments
- 10.2 Comparison by Distribution Channel
- 10.3 Online - Market size and forecast 2025-2030
- 10.4 Offline - Market size and forecast 2025-2030
- 10.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Israel - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Turkey - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global aging population statistics
- Shift toward proactive preventive healthcare
- Technological advancements in sequencing tools
- 13.2 Market challenges
- Stringent government regulatory compliance policies
- Risks regarding patient data privacy
- Rising costs of advanced panels
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Microbiome analysis for personalized wellness
- Multicancer early detection liquid biopsies
- Integration of telehealth with testing
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 23andMe Holding Co.
- 23andMe Holding Co. - Overview
- 23andMe Holding Co. - Business segments
- 23andMe Holding Co. - Key offerings
- 23andMe Holding Co. - Segment focus
- SWOT
- 15.5 Ancestry
- Ancestry - Overview
- Ancestry - Product / Service
- Ancestry - Key offerings
- SWOT
- 15.6 Any Lab Test Now Inc.
- Any Lab Test Now Inc. - Overview
- Any Lab Test Now Inc. - Product / Service
- Any Lab Test Now Inc. - Key offerings
- SWOT
- 15.7 Direct Laboratory Services LLC
- Direct Laboratory Services LLC - Overview
- Direct Laboratory Services LLC - Product / Service
- Direct Laboratory Services LLC - Key offerings
- SWOT
- 15.8 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
- 15.9 Everlywell Inc.
- Everlywell Inc. - Overview
- Everlywell Inc. - Product / Service
- Everlywell Inc. - Key offerings
- SWOT
- 15.10 Gene by Gene Ltd.
- Gene by Gene Ltd. - Overview
- Gene by Gene Ltd. - Product / Service
- Gene by Gene Ltd. - Key offerings
- SWOT
- 15.11 Laboratory Corp.
- Laboratory Corp. - Overview
- Laboratory Corp. - Business segments
- Laboratory Corp. - Key news
- Laboratory Corp. - Key offerings
- Laboratory Corp. - Segment focus
- SWOT
- 15.12 LetsGetChecked
- LetsGetChecked - Overview
- LetsGetChecked - Product / Service
- LetsGetChecked - Key offerings
- SWOT
- 15.13 Living DNA Ltd.
- Living DNA Ltd. - Overview
- Living DNA Ltd. - Product / Service
- Living DNA Ltd. - Key offerings
- SWOT
- 15.14 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key news
- Myriad Genetics Inc. - Key offerings
- SWOT
- 15.15 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
- 15.16 Segterra Inc.
- Segterra Inc. - Overview
- Segterra Inc. - Product / Service
- Segterra Inc. - Key offerings
- SWOT
- 15.17 Thorne HealthTech Inc.
- Thorne HealthTech Inc. - Overview
- Thorne HealthTech Inc. - Product / Service
- Thorne HealthTech Inc. - Key offerings
- SWOT
- 15.18 Walk In Lab LLC.
- Walk In Lab LLC. - Overview
- Walk In Lab LLC. - Product / Service
- Walk In Lab LLC. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
